10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $388,560 | +31.7% | 10,663 | +2.9% | 0.02% | +19.0% |
| Q3 2022 | $295,000 | -39.3% | 10,363 | -3.4% | 0.02% | -32.3% |
| Q2 2022 | $486,000 | -44.0% | 10,732 | -5.9% | 0.03% | -13.9% |
| Q1 2022 | $868,000 | -53.7% | 11,410 | -9.4% | 0.04% | -41.0% |
| Q4 2021 | $1,876,000 | -12.3% | 12,591 | -14.3% | 0.06% | -15.3% |
| Q3 2021 | $2,139,000 | -13.7% | 14,691 | +16.1% | 0.07% | -13.3% |
| Q2 2021 | $2,478,000 | +6.2% | 12,659 | -1.8% | 0.08% | -7.8% |
| Q1 2021 | $2,333,000 | +18.7% | 12,887 | -7.2% | 0.09% | +4.7% |
| Q4 2020 | $1,966,000 | +40.0% | 13,884 | +23.3% | 0.09% | +19.4% |
| Q3 2020 | $1,404,000 | +513.1% | 11,264 | +338.6% | 0.07% | +453.8% |
| Q2 2020 | $229,000 | – | 2,568 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |